Clincosm LogoSign in Get a demo

Cohort Study in Fujian Province

Sponsor
Fujian Provincial Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT06102187
Collaborator
Center for Disease Control and Prevention, Fujian (Other), China National Center for Cardiovascular Diseases (Other)
150,000
Enrollment
1
Location
120
Anticipated Duration (Months)
1250.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

In this study, Chinese residents aged 35 to 75 years old were recruited from Fujian Province. Physical examination, questionnaire survey and biological sample collection were performed at baseline, and at least 4 years of follow-up were conducted. Information on newly discovered cardiovascular metabolic illnesses and comorbidities was collected during follow-up, and repeated surveys similar to baseline were conducted. To explore the relationship between environment, diet and lifestyle and the risk of cardiovascular metabolic diseases and concomitant disorders.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    150000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Fujian Cohort Study of cARdiomEtabolic Disease and Comorbidity(Fu-CARE)
    Actual Study Start Date :
    Jan 1, 2017
    Anticipated Primary Completion Date :
    Dec 31, 2025
    Anticipated Study Completion Date :
    Dec 31, 2026

    Outcome Measures

    Primary Outcome Measures

    1. Coronary Disease [5 years]

      It is a form of myocardial ischemia (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

    Secondary Outcome Measures

    1. other metabolic diseases [5 years]

      Hypertension, stroke, diabetes, impaired glucose tolerance, obesity, cancer, chronic obstructive pulmonary disease, chronic kidney disease

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    35 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Aged 35-75, having lived in Fuzhou, Putian, Quanzhou, Nanping, Xiamen, Zhangzhou, Longyan, Sanming, or Ningde in Fujian Province for more than 6 months.
    Exclusion Criteria:

    • Anyone diagnosed with coronary heart disease, stroke, or cancer.

    • Anyone with a severe disability who is unable to participate in the study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Fujian Provincial Hospital Fuzhou Fujian China 350000

    Sponsors and Collaborators

    • Fujian Provincial Hospital
    • Center for Disease Control and Prevention, Fujian
    • China National Center for Cardiovascular Diseases

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Kaiyang Lin, Doctor, Fujian Provincial Hospital
    ClinicalTrials.gov Identifier:
    NCT06102187
    Other Study ID Numbers:
    • LYu
    First Posted:
    Oct 26, 2023
    Last Update Posted:
    Oct 26, 2023
    Last Verified:
    Oct 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Kaiyang Lin, Doctor, Fujian Provincial Hospital
    Cardiovascular and metabolic disease comorbidity
    Additional relevant MeSH terms:
    Chronic Disease

    Study Results

    No Results Posted as of Oct 26, 2023